4 Buys to Beat the Market

As long as the economy continues to buzz along and the Fed does not run wild with interest rates, the stock market will find reason to advance. More 

MARCH MADNESS: Visa (V) vs. CVS Health (CVS)

In a competition as tight as the one between Visa and CVS Health, you've got to get pretty granular to declare a winner. More 

MARCH MADNESS: BlackRock (BLK) vs. CVS Health (CVS)

CVS Health (CVS) and BlackRock (BLK) both have strong demographics and macro factors aiding results, but one has distinct advantages for outperformance. More 

MARCH MADNESS: Amgen (AMGN) vs. CVS Health (CVS)

Amgen (AMGN) and CVS Health Corp (CVS) find themselves on opposite sides when it comes to pricing for the latest drugs. More 

3 High-Yield Closed-End Funds

Closed-end funds are often overlooked sources for high-yield income streams. Here are three of the best. More 

Rite Aid Makes the Right Move (RAD)

Today's announcement that Rite Aid will be acquiring EnvisionRX, a PBM, is a sign the company is heading in the right direction. More 

CVS Stock Is Unfazed by Company Rebranding

Some thought CVS stock would take a big hit after the company removed tobacco products from stores last year, but Medicaid expansion has offset the loss in revenue. More